[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
date : 9/6/2021
Tags: AMR
![[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/AMR-case01_ENG.jpg)
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun a project to publish case studies showing actual cases in which antimicrobials were and were not used as examples of antimicrobial stewardship.
In this first case study, Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital) reports on a case of “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment.”
For further information, please see the case study below.
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)